The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Friday, April 17, 2015 11:01:21 PM

Featured Columnists

Clinical Trial Participation: ‘Is It All Worth It?’ Lee M. Krug, MD  

Health-Care Fraud and Abuse: Implications for Oncology Z. Kevin Lu, PhD, Brian Chen, JD, PhD, Zaina Qureshi, PhD, MPH, Oliver Sartor, MD, and Charles Bennett, MD, PhD, MPP  

Big Data and the Promise of Precision Medicine in Cancer Peter P. Yu, MD, FASCO  

More Featured Columnists

Expert Opinions

The Emerging Role of Radiation Therapy in Gastrointestinal Cancers Theodore S. Hong, MD  

Why Just Having ‘Good’ Communication Skills Is Not Enough for Talking With Seriously Ill Patients Anthony L. Back, MD  

The Ongoing Struggle Against Tobacco: Past Accomplishments, Future Steps John Seffrin, PhD  

More Expert Opinions

Meeting News

No Survival Benefit From Adjuvant Sorafenib or Sunitinib in Kidney Cancer Should Oncologists Be Ordering Breast Cancer Gene Panels? Too Early to Use Genome Sequencing for Breast Cancers in the Clinic Androgen-Deprivation Therapy Added to Radiation Therapy Improves Disease C... More Meeting News

Journal Spotlight

Immune Gene Profile Strongly Associated With Benefit of Adjuvant Trastuzum... No Benefit of High- vs Standard-Dose Radiotherapy or Addition of Cetuximab... No Overall Survival Difference for Immediate vs Deferred Chemotherapy Afte... Increased Progression-Free Survival With Addition of Carfilzomib to Lenali... More Journal Spotlights

Health-Care Policy

Health-Care Fraud and Abuse: Implications for Oncology Ongoing Controversies in Allocating Our Health‑Care Resources New Oncology Care Model: Encouraging Better Coordination for Cancer Care Medicine Turned Upside Down More Health-care Policy

Drugs & Regimens

Evidence Mounts for Clinical Utility of AR-V7 in Treatment Selection for Advanced Prostate Cancer Cabozantinib Fails to Improve Survival in Metastatic Castration-Resistant Prostate Cancer Breast Cancer Management in Review Increased Progression-Free Survival With Addition of Carfilzomib to Lenalidomide/Dexamethasone in Relapsed Multiple Myeloma More Drugs & Regimens

Oncology Worldwide

Global Oncology Launches Global Cancer Project Map With NCI Addressing the Global Cancer Burden Breast Health Global Initiative Tackles Third-World Health Care Breaking the Silence About Breast Cancer in the Arab World More Oncology Worldwide

Patient's Corner

I Refuse to Capitulate to Cancer Having Cancer So Early in Life Gave Me Purpose Cancer Was My Wake-Up Call to a Healthier Life Twenty Years After a Diagnosis …  and Counting More Patient's Corner
More on Twitter